Bristol Myers Squibb (BMS) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Hous…
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the start of construction on a new research and development (R&D) facility at its Milan, Italy site. This $30 million investment will add advanced analytical development and process R&D capabilities, alongside upgra…
To meet growing customer demand globally, WuXi AppTec is increasing its capital expenditure at least 17% in 2026 to between RMB 6.5 billion and RMB 7.5 billion, as the company looks to add new drug substance and drug product manufacturing capacity over the next two years in Asia, Europe, and the United States. Among …
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., has launched a state-of-the-art spray drying suite at its dedicated peptide development and manufacturing facility in Turbhe, India. This strategic expansion enables PPS to address the…
QIMR Berghofer and James Cook University (JCU) have strengthened their strategic partnership to create one of Australia's leading collaborations in tropical health research, accelerating the development of new vaccines, diagnostics and therapeutics while building the next generation of health researchers. Following t…
Meissner Corporation announced the opening of its first dedicated office location in Singapore, a new step in the company's long-standing commitment to the Asia-Pacific region. The move extends Meissner's reach in the Asia-Pacific region and positions the company closer to the clients, partners, and industries it serv…
As health and wellness brands look beyond traditional retail for growth, the independent drug channel is emerging as an increasingly important opportunity. To help manufacturers capitalize on that shift, Acosta has partnered with Salvatori-Scott Inc. (SSI), combining national retail capabilities with specialized exper…
Robinson Pharma, Inc., a leading USA-based manufacturer of dietary supplements, proudly announces the opening of its newest facility in Irvine, California. As the company's 10th warehouse location, this expansion reflects Robinson Pharma's ongoing commitment to innovation and long-term growth. The Irvine facility fur…
CereVasc, Inc., a clinical-stage medical device company developing minimally invasive treatments for neurological diseases, announced the opening of its new manufacturing and research facility in Wilmington, Massachusetts, following two major milestones: completion of enrollment in its STRIDE pivotal trial and the cl…
Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina. The $1.5 billion project is expected to bring 1,500 full-t…
Page 1 of 58